Everything you need to know about GoodWay.
Questions from investors, wealth managers, and institutions. Can't find what you need? Contact us.
GoodWay is an integrated ethical investment framework built on Christian Social Teaching (CST), not the ESG regulatory agenda. The core difference is the question each framework asks. ESG asks: what is the environmental and social impact? GoodWay asks: is this company coherent with the dignity of human life and the common good? ESG does not contemplate the dignity of human life as an independent criterion. GoodWay places it at the centre. A company can score well on ESG and fall short of GoodWay criteria because of pharmaceutical involvement in embryo research or abortion services financing. GoodWay and ESG are not rivals. They answer different questions.
Approximately 30% of the market capitalisation of major global indices, including the MSCI World, S&P 500, and STOXX Europe 600, does not meet Christian Social Teaching criteria. This means that a significant portion of assets held by Christian investors through standard passive index funds may be financing activities contrary to their values, including abortion services and embryo experimentation. 61.8% of investors worldwide hold passive index funds, making this a structural and widespread issue, not a marginal one. (Source: GoodWay Research / Russell Investments.)
The GoodWay Rating is a proprietary assessment system that rates 13,000+ companies, 46,000 fund classes, and 4,000 ETFs against CST and Mensuram Bonam criteria, validated by an independent Ethics Committee. It powers a three-step framework. Step 1, Rating: every position receives a GoodWay Score (0–100) against CST criteria, detecting misalignment. Step 2, Diagnosis: for every flagged position, we map the exact CST criterion violated, the philosophical reasoning, and the percentage exposure. Step 3, Alternatives: our ETS Similarity Score algorithm identifies a verified ethical replacement for every non-compliant position, matched on risk profile with validated historical return data. GoodWay is the only system that delivers all three steps as an integrated framework.
The ETS Similarity Score is GoodWay's proprietary machine learning algorithm. Given any portfolio position that falls short of CST criteria, the algorithm searches the full GoodWay rated universe and returns ethical alternatives matching the original on three dimensions: risk and return profile (beta, volatility, historical performance), sector and geographic exposure, and full CST compliance. Every recommendation includes 5-year historical return validation. The ETS Similarity Score is the empirical answer to the objection that ethical investing requires accepting lower returns.
No. The ETS Similarity Score specifically addresses this objection with data. Every ethical alternative it recommends is validated with 5-year historical performance data alongside the replaced position. Ethical no longer means underperformance. That is a design requirement of the GoodWay Rating, not a hope.
Mensuram Bonam is the 2022 Vatican document that updates Christian Social Teaching criteria for contemporary investment management. It is the most authoritative modern framework for faith-based investing, integrating traditional CST principles with current financial market realities. The philosophical lineage traces from Aristotle through Thomas Aquinas to the modern CST tradition codified in Rerum Novarum (1891). GoodWay integrates Mensuram Bonam as a core methodological foundation alongside this broader philosophical heritage.
No. GoodWay's ethical framework is built on classical philosophy (Aristotle, the concept of the common good, the dignity of human life) whose arguments are accessible to any investor regardless of religious belief. The GoodWay Decalogue makes this explicit: "Christian Social Teaching helps us clarify these positions on the dignity of human life, the common good, and the ethical use of resources, although the reasons why certain practices are contrary to human good are accessible to every human being." Any client who regards the dignity of human life as an investment criterion, religious or not, is GoodWay's audience.
Yes. GoodWay offers a professional licensing model starting at €10,000/year. Professionals can generate unlimited individual and portfolio-level reports, branded with their corporate identity. The service is fully anonymous from the end client's perspective. API integration is available. Custom enterprise pricing is available for large institutions.
Yes. Three GoodWay investment funds are coming: the first vehicles in the Spanish market constructed and maintained entirely under GoodWay Rating criteria, with ongoing ETS Similarity Score monitoring. Distribution through Arquitectura Abierta Madrid. To receive fund information when available, join the early access list on the For Investors page.
GoodWay is a product of ETS Asset Management Factory (EAF), a regulated entity with over 35 years of operation, and Alveus Investing, a licensed brokerage firm. ETS has been providing quantitative investment advisory services since 1987, currently advising €3.4 billion in assets. The GoodWay Rating itself is a proprietary analytical framework, not a financial product, and its criteria are validated by an independent Ethics Committee comprising six professors and jurists specialising in philosophy of law, moral theology, social ethics, bioethics, corporate law, and financial ethics.
The GoodWay Ethics Committee comprises seven independent professors and jurists from leading academic institutions. Their fields of expertise span philosophy of law, moral theology, social ethics, bioethics, corporate law, and financial ethics. The Committee's role is to validate every CST criterion applied in the GoodWay Rating, ensure philosophical rigour, and issue mandatory resolutions on any disputed entity. Their independence is structural: they operate outside ETS and Alveus governance. Full Committee member profiles are available on request.
CBIS and Ave Maria apply exclusion screens: binary include/exclude decisions at the sector level. GoodWay takes a fundamentally different approach. First, GoodWay provides a granular 0–100 score per holding, not a pass/fail label. Second, every score maps to specific CST criteria (not generic categories), with the philosophical reasoning behind each assessment documented and transparent. Third, where a position falls short, GoodWay generates verified alternatives via the ETS Similarity Score, matching risk profile, sector exposure, and historical returns. CBIS and Ave Maria are primarily US-focused fund managers; GoodWay is a global analytical framework covering 13,000+ companies and 46,000+ fund classes. Different instruments for different needs, but only GoodWay provides diagnosis, reasoning, and alternatives as an integrated system.